Teladoc Health, Inc. (TDOC) Dividend History

Company News

• 1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid

  The article discusses two stocks - Moderna, a beaten-down stock with decent prospects, and Teladoc Health, a company whose future looks dim. Moderna has made significant clinical progress and has a deep pipeline of potential products, while Teladoc Health has faced several headwinds, including a competitive landscape and declining subscriber numbers.

  The Motley Fool

  Featured Companies: MRNA
• Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08

  Teladoc Health, the global leader in virtual care, announced inducement awards to new employees in connection with the acquisition of Uplift Health Technologies. The company also reported its financial results for the first quarter of 2025.

  GlobeNewswire Inc.
• U.S. Virtual Care Market Insights Report 2025-2034: Revenues to Grow Exponentially, Reaching $69.2 Billion by 2034 at 29.2% CAGR

  The U.S. virtual care market is projected to grow exponentially, reaching $69.2 billion by 2034 at a CAGR of 29.2%. This growth is driven by the rising demand for digital health platforms, telehealth, and remote patient monitoring solutions, particularly in underserved areas.

  GlobeNewswire Inc.

  Featured Companies: AMWL CI CVS ORCL PHG UNH
• Teladoc Health Introduces Next Generation Cardiometabolic Health Program

  Teladoc Health introduced its next-generation Cardiometabolic Health Program to improve population health and prevent the progression of diabetes, hypertension, and obesity. The program provides tools, coaching, and support to drive healthier behaviors and better outcomes.

  GlobeNewswire Inc.
• Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks?

  The article discusses two AI healthcare stocks, Recursion Pharmaceuticals and Teladoc Health, that have underperformed the market. While both companies have ambitious AI-related plans, they face significant challenges and risks, making them risky investments.

  The Motley Fool

  Featured Companies: RXRX